Arul M. Chinnaiyan
阿鲁尔·钦纳延
MD, PhD
S.P. Hicks Professor of Pathology; Director, Michigan Center for Translational PathologyS.P.希克斯病理学教授；密歇根转化病理学中心主任
👥Biography 个人简介
Arul Chinnaiyan discovered the TMPRSS2-ERG gene fusion as the most common genomic alteration in prostate cancer, fundamentally reshaping understanding of its molecular basis. He leads one of the world's foremost cancer transcriptomics and precision oncology programs and has produced landmark multi-omic cancer atlases including the Mi-ONCOSEQ clinical sequencing program.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
TMPRSS2-ERG Gene Fusion Discovery in Prostate Cancer
Discovered the TMPRSS2-ERG chromosomal fusion as the most common recurrent gene fusion in prostate cancer (present in ~50% of cases), establishing gene fusions as drivers of common epithelial cancers.
Comprehensive Cancer Transcriptomics and Outlier Analysis
Developed COPA and outlier analysis methods enabling systematic discovery of recurrent gene fusions and outlier expression events in cancer transcriptomes, yielding multiple clinically relevant cancer drivers.
Mi-ONCOSEQ Clinical Precision Oncology Program
Established the Michigan Oncology Sequencing (Mi-ONCOSEQ) program integrating whole exome, transcriptome, and cfDNA sequencing for advanced cancer patients, demonstrating clinical utility of comprehensive molecular profiling.
Representative Works 代表性著作
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer
Science (2005)
Discovery of TMPRSS2-ERG as the most common recurrent genomic fusion in prostate cancer, establishing the role of androgen-driven gene fusions in carcinogenesis.
The transcriptional landscape of the mammalian genome
Science (2005)
ENCODE-affiliated transcriptome mapping revealing pervasive transcription beyond annotated genes, reshaping understanding of the functional cancer genome.
Integrative clinical sequencing in the management of refractory or relapsed cancer in youth
JAMA (2015)
Demonstrated clinical actionability of integrated whole-exome and RNA sequencing in pediatric refractory cancers, providing a precision oncology framework for clinical genomic sequencing programs.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 阿鲁尔·钦纳延 的研究动态
Follow Arul M. Chinnaiyan's research updates
留下邮箱，当我们发布与 Arul M. Chinnaiyan（University of Michigan Rogel Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment